Silveira Erika Aparecida, Santos Annelisa Silva E Alves de Carvalho, Ribeiro Jessivane Nascimento, Noll Matias, Dos Santos Rodrigues Ana Paula, de Oliveira Cesar
Faculty of Medicine, Postgraduate Program in Health Sciences, Federal University of Goias, Goiania, Brazil.
Affiliate Academic, Department of Epidemiology and Public Health, University College London, London, UK.
BMC Gastroenterol. 2021 May 12;21(1):217. doi: 10.1186/s12876-021-01806-5.
Constipation and obesity have common risk factors. However, little is known about the occurrence of constipation in individuals with severe obesity and the associated factors.
To evaluate the prevalence of intestinal constipation and its associated factors in adults with obesity class II and III.
This study analyzed baseline data from a randomized clinical trial with adults aged 18-64 with a Body Mass Index (BMI) ≥ 35 kg/m, living in the metropolitan region of Goiânia, Brazil. Data were collected using a questionnaire containing sociodemographic, lifestyle, level of obesity, presence of comorbidities, water intake and food consumption variables. The outcome variable was constipation assessed by the Rome III criteria and the Bristol Stool Form Scale. Multiple Poisson regression analysis was used to assess the association between explanatory variables and the outcome.
Among the 150 participants, the prevalence of constipation was 24.67% (95% CI: 17.69-31.64). After multiple regression analyses constipation was associated with polypharmacy (adjusted PR: 2.99, 95% CI: 1.18-7.57, p = 0.021), younger age group i.e. 18-29 years (adjusted PR: 3.12, 95% CI: 1.21-8.06, p = 0.019) and former smoking (adjusted PR: 3.24, 95% CI: 1.28-9.14, p = 0.014). There was no statistically significant association between constipation and daily consumption of fiber-rich foods, however, the non-consumption of whole grains was borderline significant (adjusted PR: 2.92, 95% CI: 1.00 to 8.49, p = 0.050).
A high prevalence of constipation was found in adults with obesity class II and III. Constipation was significantly associated with the simultaneous use of five or more medications, younger age group and being a former smoker.
便秘和肥胖有共同的风险因素。然而,对于重度肥胖个体中便秘的发生情况及其相关因素知之甚少。
评估II级和III级肥胖成年人肠道便秘的患病率及其相关因素。
本研究分析了一项随机临床试验的基线数据,该试验的受试者为年龄在18 - 64岁、体重指数(BMI)≥35 kg/m²、居住在巴西戈亚尼亚大都市地区的成年人。通过一份包含社会人口统计学、生活方式、肥胖程度、合并症情况、水摄入量和食物消费变量的问卷收集数据。结局变量是根据罗马III标准和布里斯托大便形状量表评估的便秘情况。采用多元泊松回归分析来评估解释变量与结局之间的关联。
在150名参与者中,便秘的患病率为24.67%(95%置信区间:17.69 - 31.64)。经过多元回归分析,便秘与多种药物联用(调整后的PR:2.99,95%置信区间:1.18 - 7.57,p = 0.021)、较年轻年龄组即18 - 29岁(调整后的PR:3.12,95%置信区间:1.21 - 8.06,p = 0.019)以及既往吸烟(调整后的PR:3.24,95%置信区间:1.28 - 9.14,p = 0.014)相关。便秘与富含纤维食物的每日摄入量之间无统计学显著关联,然而,未食用全谷物具有临界显著性(调整后的PR:2.92,95%置信区间:1.00至8.49,p = 0.050)。
在II级和III级肥胖成年人中发现便秘的患病率较高。便秘与同时使用五种或更多药物、较年轻年龄组以及既往吸烟显著相关。